1. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. Issue 11 (14th July 2022) Authors: Torregrosa, Cécile; Pernot, Simon; Vaflard, Pauline; Perret, Audrey; Tournigand, Christophe; Randrian, Violaine; Doat, Solene; Neuzillet, Cindy; Moulin, Valérie; Stouvenot, Morgane; Roth, Gael; Darbas, Tiffany; Auberger, Benjamin; Godet, Tiphaine; Jaffrelot, Marion; Lambert, Aurélien; Dubreuil, O... Journal: International journal of cancer Issue: Volume 151:Issue 11(2022) Page Start: 1978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗